TCI uses cookies to personalize and improve your user experience. By continuing on our website, you accept the use of cookies. You can change or update your cookiesettings at any time.
Maximum quantity allowed is 999
Shipping simulation can be checked by selecting the quantity from 1 to 999 with the - or + button or directly entering then clicking the magnifying glass mark.The number on the left is the quantity that can be shipped according to that schedule.
CAS RN: 220904-83-6 | Product Number: G0609
GW-5074

Purity: >95.0%(HPLC)
- 3-(3,5-Dibromo-4-hydroxybenzylidene)-5-iodoindolin-2-one
Size | Unit Price | Same Day | 2-3 Business Days | Other Lead Time |
Shipping Information
![]() |
---|---|---|---|---|---|
100MG |
A$486.00
|
12 | 0 | Contact Us |
* ChemSupply Australia Pty Ltd (Phone: 08-8440-2000 / email: sales@chemsupply.com.au)
- current tab: current tab: General Information
- Specifications & Properties
- Safety & Regulations
- Applications & Literature
Product Number | G0609 |
Purity / Analysis Method | >95.0%(HPLC) |
Molecular Formula / Molecular Weight | C15H8Br2INO2 = 520.95 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
Store Under Inert Gas | Store under inert gas |
Condition to Avoid | Light Sensitive,Air Sensitive |
Packaging and Container | 100MG-Glass Bottle with Plastic Insert (View image) |
CAS RN | 220904-83-6 |
Reaxys Registry Number | 8641129 |
MDL Number | MFCD09971042 |
Appearance | White to Yellow powder to crystal |
Purity(HPLC) | min. 95.0 %(total of isomers) |
NMR | confirm to structure |
Melting Point | 262 °C |
RTECS# | NM3249100 |
H.S.code* | 2933.79-000 |
References
- 1) The discovery of potent cRaf1 kinase inhibitors
- 2) Untying the regulation of the Raf-1 kinase (a review)
- 3) Structural model of the dimeric Parkinson’s protein LRRK2 reveals a compact architecture involving distant interdomain contacts
- 4) Inhibitors of LRRK2 kinase attenuate neurodegeneration and Parkinson-like phenotypes in Caenorhabditis elegans and Drosophila Parkinson's disease models
- 5) LRRK2 G2019S mutation attenuates microglial motility by inhibiting focal adhesion kinase
- 6) Development of LRRK2 Inhibitors for the Treatment of Parkinson's Disease (a review)
Articles/Brochures
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
Specifications
The requested specifications are not available.
Please Contact Us for more information.
C of A & Other Certificates
• Please check that the lot number you have entered is correct. It is 4-5 alphanumeric characters before the hyphen. In particular, please check O (letter) or 0 (number) and I (letter) or 1 (number).
• If your information is correct and you are still not able to view the requested certificates, Please Contact Us for more information.
The product with the lot number searched for has been discontinued and no related documentation is available.
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.
The product with the lot number searched for has been discontinued and no related documentation is available.
Other Documents
TCI uses cookies to personalize and improve your user experience. By continuing on our website, you accept the use of cookies. You can change or update your cookiesettings at any time.
Select Country or Region & Language
Americas
Europe
Asia Pacific
Africa & Middle East

-
Account

Americas
- Argentina (English)
- Brazil (English)
- Canada (English)
- Canada (Français)
- Mexico (English)
- United States (English)
- Other Americas
Europe
- Austria (Deutsch)
- Austria (English)
- Belgium (Nederlands)
- Belgium (Français)
- Belgium (English)
- Bulgaria (English)
- Croatia (English)
- Cyprus (English)
- Czech Republic (English)
- Denmark (English)
- Estonia (English)
- Finland (English)
- France (Français)
- France (English)
- Germany (Deutsch)
- Germany (English)
- Greece (English)
- Hungary (English)
- Ireland (English)
- Italy (English)
- Latvia (English)
- Liechtenstein (Deutsch)
- Liechtenstein (English)
- Lithuania (English)
- Luxembourg (English)
- Luxembourg (Français)
- Luxembourg (Deutsch)
- Malta (English)
- Netherlands (Nederlands)
- Netherlands (English)
- Norway (English)
- Poland (English)
- Portugal (English)
- Romania (English)
- Slovakia (English)
- Slovenia (English)
- Spain (English)
- Sweden (English)
- Switzerland (Deutsch)
- Switzerland (Français)
- Switzerland (English)
- Turkey (English)
- United Kingdom (English)
- Other Europe
Asia Pacific
- Australia (English)
- China [Hong Kong] (English)
- China [Mainland] (简体中文)
- India (English)
- Indonesia (English)
- Japan (日本語)
- Japan (English)
- Korea (South) (한국어)
- Korea (South) (English)
- Malaysia (English)
- New Zealand (English)
- Philippines (English)
- Singapore (English)
- Singapore (简体中文)
- Taiwan (繁體中文)
- Taiwan (English)
- Thailand (English)
- Vietnam (English)
- Other Asia Pacific
Africa & Middle East
Maximum quantity allowed is 999
Shipping simulation can be checked by selecting the quantity from 1 to 999 with the - or + button or directly entering then clicking the magnifying glass mark.The number on the left is the quantity that can be shipped according to that schedule.